Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients
Objective. This study was aimed to evaluate the prevalence of Cushing’s syndrome and the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients.
Main Authors: | Baldane Suleyman, Celik M, Kebapcilar Levent, Ipekci Suleyman Hilmi, Abusoglu Sedat, Yilmaz Huseyin, Alptekin Husnu |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-10-01
|
Series: | Endocrine Regulations |
Subjects: | |
Online Access: | https://doi.org/10.2478/enr-2022-0028 |
Similar Items
-
Diagnostic value of salivary cortisol in 1-mg dexamethasone suppression test
by: Zhanna E. Belaya, et al.
Published: (2020-06-01) -
Cortisol and the Dexamethasone Suppression Test as a Biomarker for Melancholic Depression: A Narrative Review
by: Martin M. Schumacher, et al.
Published: (2023-05-01) -
Dexamethasone suppression for 18F-FDG PET/CT to localize ACTH-secreting pituitary tumors
by: Kyungwon Kim, et al.
Published: (2023-09-01) -
Comparison of scoring systems for predicting remission of type 2 diabetes in sleeve gastrectomy patients
by: Baldane Suleyman, et al.
Published: (2022-12-01) -
Gestasyonel diabetes mellitus tanısında bir biyobelirteç olarak serum prokalsitonin düzeyi
by: Süleyman Baldane, et al.
Published: (2018-03-01)